Is Zepbound Being Taken Off the Market? Clarifying the Facts on Weight Loss Medications

Last reviewed: June 25, 2026

Last updated: June 25, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Recent supply chain discussions around branded tirzepatide products have left many patients wondering about the future of GLP-1 weight loss medications. The reality is that tirzepatide—the active ingredient in Zepbound—continues to be prescribed and remains available through multiple channels, including compounded formulations from licensed pharmacies. PlexusDx provides access to compounded tirzepatide injection starting at $249 per month, offering patients a consistent, transparent alternative regardless of brand availability fluctuations.

Understanding Zepbound Availability and Market Status

Zepbound is the FDA-approved branded version of tirzepatide manufactured by Eli Lilly. While branded medications can experience temporary supply constraints due to manufacturing, distribution, or demand factors, this does not mean the medication class is disappearing from the market. Tirzepatide remains one of the most prescribed GLP-1 receptor agonists for weight management, with clinical trials demonstrating average weight loss of 20-22% of body weight over 68 weeks. Multiple pathways exist for patients to obtain tirzepatide, ranging from brand-name prescriptions through retail pharmacies to compounded versions from licensed 503A compounding pharmacies.

The distinction between brand-name and compounded tirzepatide is important for patients evaluating their options. Both contain the same active pharmaceutical ingredient and work through identical mechanisms—activating GLP-1 and GIP receptors to regulate appetite and blood sugar. Compounded tirzepatide from licensed 503A pharmacies provides the same clinical action at a lower cost point, with PlexusDx tirzepatide injection starting at $249 per month across all dosing levels. This pricing model ensures that dose adjustments—which are medically necessary for many patients—do not trigger unexpected cost increases.

Why Compounded GLP-1 Medications Remain a Reliable Choice

Compounded medications prepared by licensed 503A compounding pharmacies operate under strict FDA oversight and state pharmacy board regulations. These facilities maintain accreditation standards, perform regular sterility and potency testing, and follow established quality protocols identical to those required for brand-name manufacturing. PlexusDx partners exclusively with 503A compounding pharmacies—never 503B facilities—to ensure every patient receives medication prepared under pharmaceutical-grade standards. This regulatory framework has allowed millions of patients to safely use compounded medications for decades, particularly when brand-name options face availability challenges or cost barriers.

The accessibility advantage of compounded tirzepatide extends beyond pricing. PlexusDx serves all 50 states without requiring insurance coverage, membership fees, or prior authorization delays that often complicate brand-name prescriptions. Patients can begin compounded tirzepatide therapy within days of their initial consultation, avoiding the treatment gaps that sometimes occur when brand-name supply becomes limited. Additionally, compounded medications are HSA and FSA eligible, allowing patients to use tax-advantaged health savings to reduce their out-of-pocket expenses further.

Comparing Tirzepatide Formulations: Injectable vs. Oral Options

PlexusDx offers both compounded tirzepatide injection and oral tirzepatide to accommodate individual patient preferences and clinical needs. Tirzepatide injection is typically administered once weekly and delivers consistent medication levels through subcutaneous delivery, making it the most common formulation in clinical trials showing the strongest weight loss outcomes. Oral tirzepatide provides an alternative for patients who prefer to avoid injections, though absorption patterns and dose requirements differ from the injectable form. Both formulations contain the identical active ingredient and produce comparable appetite-suppressing effects when dosed appropriately.

The choice between injection and oral tirzepatide often depends on patient comfort level, lifestyle factors, and individual response patterns. Some patients achieve optimal results with one formulation over the other, which is why PlexusDx offers both options at transparent, flat monthly rates. Compounded tirzepatide injection begins at $249 per month, while oral tirzepatide starts at $279 per month. Neither price changes as your prescribing provider increases your dose—ensuring predictable costs throughout your entire treatment journey, regardless of whether you require a maintenance dose or a therapeutic adjustment.

Personalized GLP-1 Selection Through Genetic Testing

Not every patient responds identically to tirzepatide, even when dose levels are equivalent. Genetic variations in the GLP-1 receptor, GIP receptor, and related metabolic pathways influence how effectively each medication works for individual patients. The Precision Peptide Genetic Test offered by PlexusDx evaluates 14 distinct peptide-related pathways, analyzes 49 different peptides, and provides 150+ genetic insights including variants like GLP1R rs6923761, GIPR rs1800437, and MC4R rs17782313. This peptide-pathway genetic assessment—distinct from standard pharmacogenomic testing—helps clinicians understand which GLP-1 compounds may produce superior outcomes for your unique biochemistry.

By combining genetic insights with clinical assessment, PlexusDx helps patients avoid unnecessary trial-and-error treatment delays. If tirzepatide is identified as an optimal match for your genetic profile, compounded tirzepatide injection delivers that targeted therapy at $249 monthly. If dual-compound therapy appears more aligned with your peptide pathway data, PlexusDx GLP-Squared Injection (combining semaglutide and tirzepatide) starts at $249 per month. The Precision Peptide Genetic Test is available as a $99 add-on after your first month of treatment, allowing your provider to refine your therapeutic approach with confidence backed by personalized genetic data.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is Zepbound actually being discontinued or removed from pharmacies?

Zepbound remains available through licensed pharmacies, though supply or distribution fluctuations can occur with any branded medication. Tirzepatide—the active ingredient in Zepbound—is not being discontinued. Compounded tirzepatide from licensed 503A pharmacies provides a consistent, accessible alternative if brand-name availability becomes limited in your area.

Is compounded tirzepatide as effective as brand-name Zepbound?

Yes. Compounded tirzepatide contains the identical active pharmaceutical ingredient as Zepbound and works through the same GLP-1 and GIP receptor mechanisms. Clinical efficacy depends on proper dosing and individual patient factors, not whether the medication is branded or compounded. PlexusDx compounded tirzepatide injection is prepared by licensed 503A pharmacies under strict FDA oversight and quality standards.

How much does PlexusDx compounded tirzepatide cost, and does the price change with dose increases?

PlexusDx compounded tirzepatide injection starts at $249 per month and remains flat across all dose levels—your dose may need to go up, but your price won't. This transparent pricing model applies whether you require a starter dose or a therapeutic adjustment, with no hidden per-dose escalations. The medication is HSA and FSA eligible, available in all 50 states, and requires no insurance.

What side effects should I expect from tirzepatide, and how do they compare between formulations?

Common side effects include nausea, vomiting, constipation, and decreased appetite—effects that typically diminish as your body adjusts over weeks to months. Injectable and oral tirzepatide produce similar side effect profiles because they contain the same active ingredient; differences in tolerability are usually individual rather than formulation-based. Your PlexusDx provider monitors your response and can adjust dosing or switch formulations if needed to optimize tolerability.

How does the Precision Peptide Genetic Test help me choose between tirzepatide and other GLP-1 medications?

The Precision Peptide Genetic Test evaluates 14 peptide-related pathways and 150+ genetic insights, including GLP1R and GIPR variants that influence medication response. If your genetic profile shows strong GLP1R and GIPR activation potential, tirzepatide injection may be optimal; if other patterns emerge, dual-compound therapy or alternative GLP-1 options may perform better. This $99 add-on test after your first treatment month helps your provider personalize your therapy with confidence.

Related Reading

• Wegovy Vs Zepbound Weight Loss
• Zepbound For Weight Loss
• Maxlife Weight Loss
• Remedy Meds Weight Loss

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.